Skip to main content
Publications
Wainberg ZA, Enzinger PC, Qin S, Yamaguchi K, Wang J, Zhou X, Gnanasakthy A, Taylor K, Yusuf A, Maher I, Jamotte A, Kang YK. Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer. ESMO gastrointestinal oncology. 2024 Dec;6. doi: 10.1016/j.esmogo.2024.100095
Mannion L, Watson V, Mullassery V, Nair R, Charlton T, Northover M, Enting D, Van Hemelrijck M, Khan MS, Thurairaja R, Amery S, Chatterton K, Smith K, Hughes S. Treatment preferences of patients with muscle invasive bladder cancer: a discrete choice experiment. BJUI Compass. 2024 Oct 11;5(11):1059-68. doi: 10.1002/bco2.443